Author:
Zhao Yang,Lai JiaYing,Liang RunBin,He MinKe,Shi Ming
Funder
National Key R&D Program of China
National Natural Science Foundation of China
National Science and Technology Major Project of China
Reference26 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Global Burden of Disease Cancer;JAMA Oncol 3,2017
2. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma;Cabibbo;Hepatology,2010
3. Current strategy for staging and treatment: the BCLC update and future prospects;Forner;Semin Liver Dis,2010
4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献